share this article

Joining the quest to beat Covid-19, leading pharmatech company Exscientia is using AI algorithms to identify molecular features in effective drugs and apply these within new, more successful ones. Hailed as the first company to automate drug discovery, Exscientia recently used AI to make obsessive compulsive disorder (OCD) drugs test-ready in 12 months instead of the standard 4-5 years. Their Covid19 development work will similarly utilise AI to repurpose existing treatments, with a novel medicine aimed at combatting the virus forecast for 12 months’ time.

share this article